• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

空间转录组学揭示了与急性胃肠道移植物抗宿主病中类固醇反应性相关的独特组织生态位。

Spatial transcriptomics reveals distinct tissue niches linked with steroid responsiveness in acute gastrointestinal GVHD.

机构信息

Center for Cancer Research, Mass General Cancer Center, Boston, MA.

Department of Pathology, Massachusetts General Hospital, Boston, MA.

出版信息

Blood. 2023 Nov 23;142(21):1831-1844. doi: 10.1182/blood.2023020644.

DOI:10.1182/blood.2023020644
PMID:37699201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10731919/
Abstract

Severe acute graft-versus-host disease (aGVHD) is associated with significant mortality and morbidity, especially in steroid-resistant (SR) cases. Spatial transcriptomic technology can elucidate tissue-based interactions in vivo and possibly identify predictors of treatment response. Tissue sections from 32 treatment-naïve patients with biopsy-confirmed lower gastrointestinal (GI) aGVHD were obtained. The GeoMx digital spatial profiler was used to capture transcriptome profiles of >18 000 genes from different foci of immune infiltrates, colonic epithelium, and vascular endothelium. Each tissue compartment sampled showed 2 distinct clusters that were analyzed for differential expression and spatially resolved correlation of gene signatures. Classic cell-mediated immunity signatures, normal differentiated epithelial cells, and inflamed vasculature dominated foci sampled from steroid-sensitive cases. In contrast, a neutrophil predominant noncanonical inflammation with regenerative epithelial cells and some indication of angiogenic endothelial response was overrepresented in areas from SR cases. Evaluation of potential prognostic biomarkers identified ubiquitin specific peptidase 17-like (USP17L) family of genes as being differentially expressed in immune cells from patients with worsened survival. In summary, we demonstrate distinct tissue niches with unique gene expression signatures within lower GI tissue from patients with aGVHD and provide evidence of a potential prognostic biomarker.

摘要

严重的急性移植物抗宿主病 (aGVHD) 与显著的死亡率和发病率相关,尤其是在类固醇耐药 (SR) 病例中。空间转录组学技术可以阐明体内组织间的相互作用,并可能确定治疗反应的预测因子。从 32 名未经治疗且活检证实患有下胃肠道 (GI) aGVHD 的患者中获得组织切片。使用 GeoMx 数字空间分析器从不同免疫浸润灶、结肠上皮和血管内皮的焦点中捕获 >18000 个基因的转录组谱。采样的每个组织隔室均显示出 2 个不同的簇,用于分析基因特征的差异表达和空间分辨相关性。来自类固醇敏感病例的样本中主要是经典的细胞介导免疫特征、正常分化的上皮细胞和炎症血管。相比之下,在 SR 病例中,富含中性粒细胞的非经典炎症、再生上皮细胞和一些血管生成内皮反应的迹象更为突出。对潜在预后生物标志物的评估确定泛素特异性肽酶 17 样 (USP17L) 家族基因在 aGVHD 患者免疫细胞中的表达存在差异,这与生存恶化的患者有关。总之,我们在 aGVHD 患者的下胃肠道组织中展示了具有独特基因表达特征的不同组织龛位,并提供了潜在预后生物标志物的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd4/10731919/f9e5adb91821/BLOOD_BLD-2023-020644-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd4/10731919/f9e5adb91821/BLOOD_BLD-2023-020644-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd4/10731919/f9e5adb91821/BLOOD_BLD-2023-020644-ga1.jpg

相似文献

1
Spatial transcriptomics reveals distinct tissue niches linked with steroid responsiveness in acute gastrointestinal GVHD.空间转录组学揭示了与急性胃肠道移植物抗宿主病中类固醇反应性相关的独特组织生态位。
Blood. 2023 Nov 23;142(21):1831-1844. doi: 10.1182/blood.2023020644.
2
Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease.致命性肠道急性移植物抗宿主病中的应激反应、M2 巨噬细胞和独特的微生物特征。
JCI Insight. 2019 Aug 8;5(17):129762. doi: 10.1172/jci.insight.129762.
3
Differential protein expression in endothelial cells exposed to serum from patients with acute graft-vs-host disease, depending on steroid response.急性移植物抗宿主病患者血清作用下,依激素反应的内皮细胞差异蛋白表达。
J Cell Mol Med. 2023 May;27(9):1227-1238. doi: 10.1111/jcmm.17712. Epub 2023 Apr 4.
4
Pathophysiology of gastrointestinal acute graft-versus-host disease and the potential role of glucagon-like peptide 2.胃肠道急性移植物抗宿主病的病理生理学及胰高血糖素样肽 2 的潜在作用。
Br J Haematol. 2023 May;201(4):620-627. doi: 10.1111/bjh.18778. Epub 2023 Mar 25.
5
Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease.维得利珠单抗联合巴利昔单抗二线治疗激素难治性下胃肠道急性移植物抗宿主病。
Front Immunol. 2024 Jul 3;15:1408211. doi: 10.3389/fimmu.2024.1408211. eCollection 2024.
6
Steroid-Sensitive, but Not Steroid-Dependent or Steroid-Resistant Acute Graft-versus-Host Disease, Results in Similar Infection Risk as No Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation.类固醇敏感,但非类固醇依赖或类固醇耐药的急性移植物抗宿主病,在异基因造血细胞移植后与无移植物抗宿主病相比,具有相似的感染风险。
Transplant Cell Ther. 2022 Aug;28(8):509.e1-509.e11. doi: 10.1016/j.jtct.2022.05.008. Epub 2022 May 14.
7
Vedolizumab in highly resistant acute gastrointestinal graft-versus-host disease after allogeneic stem cell transplantation: A single-center pediatric series.异体造血干细胞移植后高度难治性急性胃肠道移植物抗宿主病应用维得利珠单抗:单中心儿科系列研究。
Adv Clin Exp Med. 2022 Mar;31(3):345-350. doi: 10.17219/acem/146321.
8
Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.异体造血干细胞移植后多药耐药的急性和晚期移植物抗宿主病的间充质基质细胞治疗的安全性和有效性。
Ann Hematol. 2023 Jun;102(6):1537-1547. doi: 10.1007/s00277-023-05216-3. Epub 2023 Apr 17.
9
A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.一项关于阿仑单抗作为儿童和青年成人异基因造血干细胞移植中类固醇难治性急性移植物抗宿主病二线治疗药物的前瞻性研究。
Biol Blood Marrow Transplant. 2016 Dec;22(12):2220-2225. doi: 10.1016/j.bbmt.2016.09.016. Epub 2016 Sep 21.
10
[Efficacy of basiliximab in the treatment of 87 cases of steroid-refractory or steroid-dependent acute graft-versus-host disease].巴利昔单抗治疗87例激素难治性或激素依赖性急性移植物抗宿主病的疗效
Zhonghua Xue Ye Xue Za Zhi. 2022 Feb 14;43(2):120-127. doi: 10.3760/cma.j.issn.0253-2727.2022.02.006.

本文引用的文献

1
Effective treatment of low-risk acute GVHD with itacitinib monotherapy.伊曲替尼单药治疗低危急性移植物抗宿主病的疗效。
Blood. 2023 Feb 2;141(5):481-489. doi: 10.1182/blood.2022017442.
2
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin.α-1 抗胰蛋白酶指导的生物标志物引导的类固醇难治性移植物抗宿主病的抢先治疗。
Blood Adv. 2020 Dec 22;4(24):6098-6105. doi: 10.1182/bloodadvances.2020003336.
3
Combined whole-mount fluorescence in situ hybridization and antibody staining in zebrafish embryos and larvae.
斑马鱼胚胎和幼虫的全胚胎荧光原位杂交与抗体染色联合检测。
Nat Protoc. 2020 Oct;15(10):3361-3379. doi: 10.1038/s41596-020-0376-7. Epub 2020 Sep 9.
4
Novel In Situ Hybridization and Multiplex Immunofluorescence Technology Combined With Whole-slide Digital Image Analysis in Kidney Transplantation.新型原位杂交与多重免疫荧光技术联合全切片数字图像分析在肾移植中的应用。
J Histochem Cytochem. 2020 Jul;68(7):445-459. doi: 10.1369/0022155420935401. Epub 2020 Jul 1.
5
GeoMx™ RNA Assay: High Multiplex, Digital, Spatial Analysis of RNA in FFPE Tissue.GeoMx™ RNA 分析:FFPE 组织中 RNA 的高通量、数字化、空间分析。
Methods Mol Biol. 2020;2148:331-345. doi: 10.1007/978-1-0716-0623-0_21.
6
Treatment and unmet needs in steroid-refractory acute graft-versus-host disease.类固醇难治性急性移植物抗宿主病的治疗及未满足的需求。
Leukemia. 2020 May;34(5):1229-1240. doi: 10.1038/s41375-020-0804-2. Epub 2020 Apr 3.
7
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease.MAGIC 算法概率是一种经过验证的急性移植物抗宿主病治疗反应生物标志物。
Blood Adv. 2019 Dec 10;3(23):4034-4042. doi: 10.1182/bloodadvances.2019000791.
8
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial.随机多中心试验:西罗莫司对比泼尼松作为标准风险急性移植物抗宿主病的初始治疗:BMT CTN 1501 试验。
Blood. 2020 Jan 9;135(2):97-107. doi: 10.1182/blood.2019003125.
9
Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease.致命性肠道急性移植物抗宿主病中的应激反应、M2 巨噬细胞和独特的微生物特征。
JCI Insight. 2019 Aug 8;5(17):129762. doi: 10.1172/jci.insight.129762.
10
GVHD: biology matters.移植物抗宿主病(GVHD):生物学因素很重要。
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):221-227. doi: 10.1182/asheducation-2018.1.221.